• cymabay therapeutics, inc. announces presentations at the liver meeting® 2021 marketscreener.com Sat, 12 Apr 2025 13:47:21 GMT
• cymabay therapeutics, inc. announces management changes marketscreener.com Sat, 05 Apr 2025 09:23:32 GMT
• cymabay halts development of seladelpar due to atypical histological findings in nash study FirstWord Pharma Sat, 01 Mar 2025 12:32:37 GMT
• report: developing opportunities within vereit, caredx, cymabay therapeutics, and harsco - future expectations, projections moving... ACCESS Newswire Wed, 26 Feb 2025 08:58:14 GMT
• primary biliary cholangitis market growth to accelerate in forecast period (2024-2034), delveinsight analyzes | intercept pharma, ... The Globe and Mail Thu, 10 Oct 2024 14:38:00 GMT
• why gilead sciences is buying cymabay therapeutics for $4.3 billion MSN Tue, 20 Aug 2024 08:51:34 GMT
• fda approves gilead's seladelpar for inflammatory liver disease, acquired via $4b cymabay deal MSN Sat, 17 Aug 2024 02:18:00 GMT
• Gilead’s $4.3B Bet on CymaBay Pays Off With FDA Nod for Autoimmune Liver Disease Drug BioSpace Thu, 15 Aug 2024 07:00:00 GMT
• fda approves gilead's seladelpar for inflammatory liver disease, acquired via $4b cymabay deal Yahoo Finance Thu, 15 Aug 2024 07:00:00 GMT
• Gilead gets US FDA approval for inflammatory liver disease drug Reuters Wed, 14 Aug 2024 07:00:00 GMT
• Gilead wins FDA accelerated approval of seladelpar after acquiring it in $4.3B deal Endpoints News Wed, 14 Aug 2024 07:00:00 GMT
• Gilead Liver Drug Wins FDA Approval, to Cost $12,606 a Month Bloomberg.com Wed, 14 Aug 2024 07:00:00 GMT
• fda grants accelerated approval to seladelpar (livdelzi) for primary biliary cholangitis MD Magazine Wed, 14 Aug 2024 07:00:00 GMT
• Gilead looks for FDA drug win this week, sealing a multibillion-dollar bet The Business Journals Mon, 12 Aug 2024 07:00:00 GMT
• On doorstep of FDA decision, Gilead pays J&J $320M to exit licensing deal for seladelpar Fierce Biotech Fri, 09 Aug 2024 07:00:00 GMT
• gilead shells out $320m to j&j to buy out rare liver disease drug royalties Endpoints News Thu, 08 Aug 2024 07:00:00 GMT
• 89bio appoints charles mcwherter, ph.d., to its board of directors StockTitan Mon, 05 Aug 2024 07:00:00 GMT
• dow surges over 150 points; gilead sciences to acquire cymabay therapeutics for $4.3b Quantisnow Mon, 01 Jul 2024 23:55:19 GMT
• cymabay therapeutics | biotechnology | the pharmaletter The Pharma Letter Sun, 30 Jun 2024 12:34:32 GMT
• here's why momentum in cymabay therapeutics inc. (cbay) should keep going Yahoo News Malaysia Sat, 29 Jun 2024 04:53:02 GMT
• institutional investors own a significant stake of 45% in cymabay therapeutics, inc. (nasdaq:cbay) Yahoo Movies Canada Sat, 29 Jun 2024 01:29:19 GMT
• nautic partners acquires surfaceprep in partnership with management World Business Outlook Fri, 28 Jun 2024 09:59:16 GMT
• cymabay appoints thomas wiggans and janet dorling to board of directors cymabay therapeutics, inc. Quantisnow Thu, 27 Jun 2024 20:58:22 GMT
• Gilead Sciences announces the acquisition of CymaBay Therapeutics World Business Outlook Wed, 26 Jun 2024 21:13:59 GMT
• oruka therapeutics announces key additions to leadership team and board of directors Yahoo Finance Wed, 26 Jun 2024 07:00:00 GMT
• institutional investors own a significant stake of 45% in cymabay therapeutics, inc. (nasdaq:cbay) Yahoo Movies Canada Tue, 25 Jun 2024 15:34:30 GMT
• gilead sciences announces the acquisition of cymabay therapeutics World Business Outlook Sun, 23 Jun 2024 07:24:47 GMT
• here's why momentum in cymabay therapeutics inc. (cbay) should keep going Yahoo News Malaysia Sat, 22 Jun 2024 14:09:28 GMT
• Gilead’s M&A appetite is for deals in the ‘mid-single-digit billions,’ CEO says Endpoints News Thu, 13 Jun 2024 07:00:00 GMT
• ipsen, genfit medicine is cleared by fda for rare liver disorder Bloomberg.com Mon, 10 Jun 2024 07:00:00 GMT
• gilead announces two-year interim results from assure study - tipranks.com TipRanks Thu, 06 Jun 2024 09:54:13 GMT
• Gilead, with approval in sight, shows $4.3B liver disease drug improves outcomes out to 2 years Fierce Biotech Wed, 05 Jun 2024 07:00:00 GMT
• gilead’s seladelpar demonstrated a sustained and consistent long-term efficacy and safety profile in primary biliary cholangitis Business Wire Wed, 05 Jun 2024 07:00:00 GMT
• gilead's seladelpar demonstrated a sustained and consistent long-term efficacy and safety profile in primary biliary ... Business Wire Wed, 05 Jun 2024 07:00:00 GMT
• cymabay therapeutics announces positive results from its phase 2b clinical study demonstrating that arhalofenate ... Yahoo Eurosport UK Wed, 29 May 2024 14:50:38 GMT
• cymabay therapeutics to present at upcoming conferences Yahoo News UK Wed, 22 May 2024 14:27:43 GMT
• Gilead's new liver disease med continues to deliver the goods ahead of FDA verdict Fierce Biotech Mon, 20 May 2024 07:00:00 GMT
• gilead liver disease med still delivers ahead of fda verdict Fierce Biotech Mon, 20 May 2024 07:00:00 GMT
• biopharmaceutical mergers and acquisitions surge to new highs The Economic Times Wed, 15 May 2024 07:00:00 GMT
• we think cymabay therapeutics (nasdaq:cbay) can afford to drive business growth Yahoo Canada Shine On Mon, 13 May 2024 10:46:55 GMT
• gilead posts quarterly loss on acquisition charge, revenue rises 5% MSN Sun, 12 May 2024 05:17:59 GMT
• cymabay (cbay) stock up on positive results from pbc study Yahoo Movies Canada Sat, 11 May 2024 11:00:21 GMT
• cymabay therapeutics inc. (cbay) just flashed golden cross signal: do you buy? Yahoo Canada Shine On Fri, 10 May 2024 03:39:06 GMT
• cymabay (cbay) stock up on positive results from pbc study Yahoo Movies Canada Mon, 06 May 2024 15:17:55 GMT
• cymabay therapeutics (nasdaq:cbay) coverage initiated by analysts at stocknews.com Defense World Sun, 05 May 2024 16:22:02 GMT
• gilead sciences: acquisition of cymabay therapeutics enhancing liver disease portfolio & 6 major drivers Smartkarma Sun, 05 May 2024 07:00:00 GMT
• is cymabay therapeutics (cbay) stock a solid choice right now? Yahoo New Zealand News Thu, 02 May 2024 17:00:40 GMT
• is swedish orphan biovitrum (biovf) stock outpacing its medical peers this year? Yahoo New Zealand News Wed, 01 May 2024 05:35:21 GMT
• gilead sciences: first-quarter results beat estimates The Motley Fool Mon, 29 Apr 2024 20:55:45 GMT
• cymabay therapeutics (nasdaq:cbay) coverage initiated at stocknews.com Defense World Sat, 27 Apr 2024 06:52:16 GMT
• gilead touts 5% revenue jump, positions for 2024 growth and culls pipeline BioSpace Fri, 26 Apr 2024 07:00:00 GMT
• gilead posts quarterly loss on acquisition charge, revenue rises 5% ETHealthWorld Fri, 26 Apr 2024 07:00:00 GMT
• gilead sales grow but swings to loss after cymabay buy The Pharma Letter Fri, 26 Apr 2024 07:00:00 GMT
• gilead posts quarterly loss, revenue rises 5% | the mighty 790 kfgo KFGO Thu, 25 Apr 2024 21:19:24 GMT
• gilead posts quarterly loss, revenue rises 5% SaltWire Halifax powered by The Chronicle Herald Thu, 25 Apr 2024 20:12:45 GMT
• Gilead Sciences Announces First Quarter 2024 Financial Results Business Wire Thu, 25 Apr 2024 07:00:00 GMT
• Gilead posts quarterly loss on acquisition charge, revenue rises 5% Reuters Thu, 25 Apr 2024 07:00:00 GMT
• gilead leans on cymabay liver drug, trodelvy readouts and long-active prep yet to come this year Endpoints News Thu, 25 Apr 2024 07:00:00 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) shares purchased by raymond james & associates Defense World Sat, 20 Apr 2024 17:11:41 GMT
• cymabay's stock surges as gilead reaches $4.3 billion deal for liver-drug developer MSN Sat, 20 Apr 2024 10:22:42 GMT
• institutional investors own a significant stake of 50% in cymabay therapeutics, inc. (nasdaq:cbay) Yahoo Movies UK Fri, 19 Apr 2024 11:58:40 GMT
• cymabay therapeutics inc. (cbay) upgraded to buy: what does it mean for the stock? Yahoo Lifestyle UK Wed, 17 Apr 2024 16:09:46 GMT
• cymabay therapeutics inc. (cbay) upgraded to buy: what does it mean for the stock? Yahoo Lifestyle UK Sun, 14 Apr 2024 16:25:54 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) receives consensus recommendation of “hold” from analysts Defense World Thu, 11 Apr 2024 07:05:18 GMT
• cymabay therapeutics (nasdaq:cbay) research coverage started at stocknews.com Defense World Thu, 11 Apr 2024 06:20:23 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) shares bought by raymond james financial services advisors inc. Defense World Tue, 09 Apr 2024 08:43:45 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) shares bought by vanguard group inc. Defense World Sat, 06 Apr 2024 08:21:34 GMT
• vanguard group inc. has $85.70 million position in cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Sat, 06 Apr 2024 08:18:01 GMT
• vanguard group inc. purchases 598,707 shares of cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Sat, 06 Apr 2024 08:18:01 GMT
• vanguard group inc. raises position in cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Sat, 06 Apr 2024 08:18:01 GMT
• how cymabay survived a safety scare - timmermanreport.com Timmerman Report Thu, 04 Apr 2024 07:00:00 GMT
• opthea bolsters board with biopharmaceutical expertise - tipranks.com TipRanks Thu, 04 Apr 2024 02:10:33 GMT
• fierce biotech's quarterly ipo and m&a roundup: q1'24 Fierce Biotech Wed, 03 Apr 2024 07:00:00 GMT
• cymabay therapeutics (nasdaq:cbay) earns sell rating from analysts at stocknews.com Defense World Wed, 03 Apr 2024 07:00:00 GMT
• cymabay therapeutics (nasdaq:cbay) receives new coverage from analysts at stocknews.com MarketBeat Wed, 03 Apr 2024 06:16:27 GMT
• cymabay therapeutics (nasdaq:cbay) coverage initiated at stocknews.com MarketBeat Wed, 03 Apr 2024 06:16:27 GMT
• cymabay therapeutics (nasdaq:cbay) research coverage started at stocknews.com MarketBeat Wed, 03 Apr 2024 06:16:27 GMT
• cymabay therapeutics appoints robert j. wills, ph.d. to board of directors Yahoo Singapore News Tue, 02 Apr 2024 19:03:23 GMT
• cymabay therapeutics inc. (cbay) just flashed golden cross signal: do you buy? Yahoo Movies UK Tue, 02 Apr 2024 16:20:05 GMT
• assenagon asset management s.a. acquires new stake in cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Fri, 29 Mar 2024 04:44:41 GMT
• assenagon asset management s.a. buys shares of 746,353 cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Thu, 28 Mar 2024 23:03:45 GMT
• assenagon asset management s.a. acquires new stake in cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Thu, 28 Mar 2024 20:37:30 GMT
• assenagon asset management s.a. makes new $17.63 million investment in cymabay therapeutics, inc. (nasdaq ... MarketBeat Thu, 28 Mar 2024 16:52:30 GMT
• assenagon asset management s.a. purchases new position in cymabay therapeutics, inc. (nasdaq:cbay) Defense World Thu, 28 Mar 2024 10:02:15 GMT
• assenagon asset management s.a. invests $17.63 million in cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Thu, 28 Mar 2024 09:59:05 GMT
• citigroup inc. cuts stock position in cymabay therapeutics, inc. (nasdaq:cbay) Defense World Wed, 27 Mar 2024 08:36:00 GMT
• Tvardi Therapeutics Appoints Sujal Shah as Chairman and Adds Shaheen Wirk to the Board of Directors Business Wire Tue, 26 Mar 2024 07:00:00 GMT
• stocknews.com initiates coverage on cymabay therapeutics (nasdaq:cbay) MarketBeat Tue, 26 Mar 2024 02:58:53 GMT
• stocknews.com begins coverage on cymabay therapeutics (nasdaq:cbay) MarketBeat Mon, 25 Mar 2024 21:02:24 GMT
• Gilead concludes acquisition of CymaBay Therapeutics for $4.3bn Pharmaceutical Technology Mon, 25 Mar 2024 07:00:00 GMT
• Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight GlobeNewswire Mon, 25 Mar 2024 07:00:00 GMT
• gilead sciences completes acquisition of cymabay, for approximately $4.3 billion FinSMEs Mon, 25 Mar 2024 07:00:00 GMT
• gilead sciences completes deal to buy cymabay for $4.3 billion Pulse 2.0 Mon, 25 Mar 2024 07:00:00 GMT
• cymabay therapeutics (nasdaq:cbay) coverage initiated by analysts at stocknews.com Defense World Mon, 25 Mar 2024 06:23:53 GMT
• stocknews.com initiates coverage on cymabay therapeutics (nasdaq:cbay) MarketBeat Mon, 25 Mar 2024 06:20:20 GMT
• gilead sciences completes acquisition of cymabay therapeutics for usd 4.3 billion Medical Dialogues Sun, 24 Mar 2024 07:00:00 GMT
• gilead completes cymabay acquisition but negative impact on 2024 eps MSN Sat, 23 Mar 2024 14:39:24 GMT
• gilead says cymabay deal to lower 2024 eps by $3.35-$3.45 - tipranks.com TipRanks Sat, 23 Mar 2024 13:34:03 GMT
• cymabay therapeutics: major acquisition and leadership overhaul - tipranks.com TipRanks Sat, 23 Mar 2024 07:43:55 GMT
• gilead reduces 2024 earnings guidance after completing cymabay takeover by investing.com Investing.com Australia Sat, 23 Mar 2024 07:00:00 GMT
• deutsche bank ag sells 369,851 shares of cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Sat, 23 Mar 2024 00:12:08 GMT
• deutsche bank ag has $6.80 million stock position in cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Fri, 22 Mar 2024 19:17:07 GMT
• deutsche bank ag trims stake in cymabay therapeutics, inc. (nasdaq:cbay) Defense World Fri, 22 Mar 2024 08:47:49 GMT
• deutsche bank ag sells 369,851 shares of cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Fri, 22 Mar 2024 08:18:23 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) shares sold by deutsche bank ag MarketBeat Fri, 22 Mar 2024 08:18:23 GMT
• Gilead Sciences Announces Completion of Acquisition of CymaBay Business Wire Fri, 22 Mar 2024 07:00:00 GMT
• Gilead Sciences Completes Acquisition Of CymaBay Therapeutics Nasdaq Fri, 22 Mar 2024 07:00:00 GMT
• cymabay therapeutics: major acquisition and leadership overhaul TipRanks Fri, 22 Mar 2024 07:00:00 GMT
• cymabay therapeutics, inc. announces board changes Marketscreener.com Fri, 22 Mar 2024 07:00:00 GMT
• gilead sciences bolsters portfolio with cymabay acquisition TipRanks Fri, 22 Mar 2024 07:00:00 GMT
• gilead (gild) reduces 2024 earnings guidance after completing cymabay takeover StreetInsider.com Fri, 22 Mar 2024 07:00:00 GMT
• gilead finalizes cymabay acquisition to bolster liver disease treatments by investing.com Investing.com Nigeria Fri, 22 Mar 2024 07:00:00 GMT
• gilead completes cymabay acquisition but negative impact on 2024 eps (nasdaq:gild) Seeking Alpha Fri, 22 Mar 2024 07:00:00 GMT
• gilead reduces 2024 earnings guidance after completing cymabay takeover by investing.com Investing.com Fri, 22 Mar 2024 07:00:00 GMT
• gilead says cymabay deal to lower 2024 eps by $3.35-$3.45 - tipranks.com TipRanks Fri, 22 Mar 2024 07:00:00 GMT
• cymabay therapeutics revamps executive compensation agreements TipRanks Wed, 20 Mar 2024 20:33:38 GMT
• cymabay therapeutics (nasdaq:cbay) hits new 12-month high at $32.48 MarketBeat Mon, 18 Mar 2024 18:56:15 GMT
• cymabay therapeutics (nasdaq:cbay) reaches new 52-week high at $32.48 MarketBeat Mon, 18 Mar 2024 14:58:24 GMT
• cymabay therapeutics (nasdaq:cbay) sets new 52-week high at $32.48 MarketBeat Mon, 18 Mar 2024 14:58:21 GMT
• hudson bay capital management lp acquires shares of 30000 cymabay therapeutics, inc. (nasdaq:cbay) Defense World Mon, 18 Mar 2024 09:10:38 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) given consensus rating of "hold" by analysts MarketBeat Mon, 18 Mar 2024 03:59:31 GMT
• cymabay therapeutics (nasdaq:cbay) coverage initiated by analysts at stocknews.com MarketBeat Mon, 18 Mar 2024 02:59:00 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) given consensus rating of "hold" by analysts MarketBeat Sun, 17 Mar 2024 07:01:03 GMT
CymaBay Therapeutics, Inc(NASDAQ:CBAY) 
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta, which has com...
Website: http://www.cymabay.com
Founded: 1988
Full Time Employees: 36
Sector: Healthcare
Industry: Biotechnology